NCT07460726 2026-03-10
PRIAPUS-PCa
CancerCare Manitoba
Not yet recruiting
Clinical Trials
18 trialsNCT07455422 2026-03-06
Endeavor-2
University Hospital, Antwerp
Phase NA Not yet recruiting
NCT07444983 2026-03-03
Rezvilutamide for High-Risk Prostate Cancer After Surgery
Fujian Medical University Union Hospital
Phase NA Not yet recruiting
NCT06834204 2026-02-25
ACCESS-PC
Rutgers, The State University of New Jersey
Phase NA Not yet recruiting
NCT07426055 2026-02-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT07368985 2026-01-27
Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer
Erasmus Medical Center
Phase 2 Not yet recruiting
NCT07316686 2026-01-05
Lutécio
Instituto do Cancer do Estado de São Paulo
Phase 1 Not yet recruiting
NCT07237399 2025-12-26
TA-P-OLIM
University Hospital, Ghent
Not yet recruiting
NCT07281768 2025-12-15
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Not yet recruiting
NCT07268794 2025-12-08
CONVERT-HB1
Fudan University
Phase 2 Not yet recruiting
NCT06794073 2025-08-29
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Shanghai Zhongshan Hospital
Phase NA Not yet recruiting
NCT06931496 2025-04-17
PROSTIA- BP
Central Hospital, Nancy, France
Phase NA Not yet recruiting
NCT06855589 2025-03-04
PCS-XII
Charles LeMoyne Hospital
Phase 3 Not yet recruiting
NCT06844513 2025-02-25
URO-ROBOT-2023
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Not yet recruiting
NCT06838520 2025-02-20
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting
NCT06469060 2024-07-01
TRACE
Shanghai Chest Hospital
Phase 2 Not yet recruiting
NCT06241469 2024-02-05
Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study
The First People's Hospital of Changzhou
Phase 2 Not yet recruiting
NCT04384601 2021-07-19
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
Ruijin Hospital
Phase 3 Not yet recruiting